109208 ⎘
Structure or type of the nucleic acid; Chemical structure; Nature of the modification linked to the nucleic acid via an atom other than carbon Nitrogen
ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES
#2Conjugated Antisense Compounds and Their Use
#3EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#4ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES
#5Antisense Nucleic Acids
#6EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#7ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES
#8Conjugated antisense compounds and their use
#9EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#10ANTISENSE NUCLEIC ACIDS
#11EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#12Treatment Of Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, And Liver Fibrosis
#13Exon skipping compositions for treating muscular dystrophy
#14Conjugated antisense compounds and their use
#15Antisense nucleic acids
#16EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#17EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#18SYNTHESIS OF HIGH DENSITY MOLECULAR DNA BRUSHES VIA ORGANIC-PHASE RING-OPENING METATHESIS (CO)POLYMERIZATION
#19ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES
#20Exon skipping compositions for treating muscular dystrophy
#21Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
#22Antisense Polynucleotides to Induce Exon Skipping and Method of Treating Dystrophies
#23ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHODS OF TREATING DYSTROPHIES
#24EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#25EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#26EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#27SELF-ASSEMBLED, ELECTRONICALLY-FUNCTIONAL NUCLEIC ACID NANOSTRUCTURES AND NETWORKS BASED ON THE USE OF ORTHOGONAL BASE PAIRS
#28Polynucleotide agents targeting aminolevulinic acid synthase-1 (ALAS1) and uses thereof
#29Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
#30Antisense polynucleotides to induce exon skipping and methods of treating dystrophies
#31Methods and compositions involving miRNA and miRNA inhibitor molecules
#32Methods and compositions involving miRNA and miRNA inhibitor molecules
#33Antisense polynucleotides to induce exon skipping and methods of treating dystrophies
#34Aptamer which selectively binds to ERBB2 receptor and uses thereof
#35Methods and compositions involving miRNA and miRNA inhibitor molecules
#36Exon skipping compositions for treating muscular dystrophy
#37Methods and compositions involving miRNA and miRNA inhibitor molecules
#38METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#392' Deoxy-2'-Alkylnucleotide Containing Nucleic Acid
#40Methods and compositions involving miRNA and miRNA inhibitor molecules
#41Methods and compositions involving miRNA and miRNA inhibitor molecules
#42Methods and compositions involving miRNA and miRNA inhibitor molecules
#43Methods and compositions involving miRNA and miRNA inhibitor molecules
#44Synthesis, deprotection, analysis & purification of RNA & ribozymes
#452'-deoxy-2'alkylnucleotide containing nucleic acid
#46Polymearase III-based expression of therapeutic RNAs
#472' Modified oligonucleotides